Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Solid, Malignant Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00557505
What this trial is testing

PF-03732010 In Patients With Advanced Solid Tumors

Who this might be right for
Neoplasms
Pfizer 43
Testing effectiveness (Phase 2)Looking for participantsNCT06616766
What this trial is testing

A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)Solid Tumor
Yuhan Corporation 201
Early research (Phase 1)Looking for participantsNCT06541639
What this trial is testing

EVM16 Injection as a Single and Combination With Tislelizumab in Solid Tumors

Who this might be right for
Advanced or Recurrent Solid Tumors
Peking University 78
Early research (Phase 1)UnknownNCT05277454
What this trial is testing

Clinical Study of HMPL-653 in Treatment of Advanced Malignant Solid Tumors and TGCT

Who this might be right for
Advanced Malignant Solid TumorsTGCT
Hutchison Medipharma Limited 113
Early research (Phase 1)UnknownNCT05420545
What this trial is testing

A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors

Who this might be right for
Metastatic TumorAdvanced Solid TumorRenal Cell Carcinoma+2 more
Chongqing Precision Biotech Co., Ltd 36
Early research (Phase 1)Study completedNCT01949545
What this trial is testing

Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Advanced Malignancies and Hepatic Impairment

Who this might be right for
Solid TumorsHematologic MalignanciesHepatic Impairment
Amgen 46
Early research (Phase 1)Study completedNCT02171637
What this trial is testing

Dose Escalation Study of Oral Treatment With BIBW 2992 in Patients With Advanced Solid Tumors

Who this might be right for
Neoplasms
Boehringer Ingelheim 38
Early research (Phase 1)Looking for participantsNCT07288957
What this trial is testing

A Early Study of ABSK131 in Patients With Advanced/Metastatic Solid Tumors

Who this might be right for
Solid Tumors (Phase 1)
Abbisko Therapeutics Co, Ltd 266
Testing effectiveness (Phase 2)Ended earlyNCT03681951
What this trial is testing

First-time-in-human (FTIH) Study of GSK3145095 Alone and in Combination With Other Anticancer Agents in Adults With Advanced Solid Tumors

Who this might be right for
Neoplasms, Pancreatic
GlaxoSmithKline 8
Early research (Phase 1)Study completedNCT02748837
What this trial is testing

ERY974 in Patient With Advanced Solid Tumors

Who this might be right for
Solid Tumors
Chugai Pharmaceutical 29
Early research (Phase 1)Study completedNCT00120939
What this trial is testing

Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer

Who this might be right for
Breast NeoplasmsOvarian NeoplasmsProstatic Neoplasms+2 more
Pharmacyclics LLC. 25
Early research (Phase 1)Study completedNCT02354898
What this trial is testing

BBI503 in Advanced Solid Tumors, or BBI503/ Sorafenib in Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Solid TumorsHepatocellular Carcinoma
Sumitomo Pharma Co., Ltd. 60
Early research (Phase 1)WithdrawnNCT00601614
What this trial is testing

Vandetanib and Temozolomide in Treating Patients With Advanced Solid Tumors That Cannot Be Removed By Surgery

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Mayo Clinic
Testing effectiveness (Phase 2)Looking for participantsNCT06117540
What this trial is testing

WX390 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Shanghai Jiatan Pharmatech Co., Ltd 70
Early research (Phase 1)Active Not RecruitingNCT05914376
What this trial is testing

Safety of Recombinant Human IL-21-expressing Oncolytic Vaccinia Virus Injection (hV01) in Advanced Tumors

Who this might be right for
Advanced Solid Tumors
Hangzhou Converd Co., Ltd. 24
Early research (Phase 1)Study completedNCT00849550
What this trial is testing

Safety and Dosage Study of RAD001 (Everolimus) in Combination With Current Standard of Care to Treat Advanced Solid Tumors.

Who this might be right for
Unspecified Adult Solid Tumor, Protocol SpecificCancer
Herbert Hurwitz 32
Early research (Phase 1)Study completedNCT04261413
What this trial is testing

Phase Ia/Ib Study of RS-0139 in Patients With a Recurrent, Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumors
RS Arastirma Egitim Danismanlik Ilac Sanayi Ticaret A.S. 16
Not applicableStudy completedNCT02724488
What this trial is testing

Selection Pressure and Evolution Induced by Immune Checkpoint Inhibitors and Other Immunologic Therapies

Who this might be right for
Head and Neck CancerMelanoma
University Health Network, Toronto 14
Early research (Phase 1)Study completedNCT00054548
What this trial is testing

Combination Chemotherapy Plus Oblimersen in Treating Patients With Advanced Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 55
Testing effectiveness (Phase 2)Looking for participantsNCT05367778
What this trial is testing

Phase 1/2 Study of HS-10370 in Patients with Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
Jiangsu Hansoh Pharmaceutical Co., Ltd. 176
Next Page